---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-011945"
form_type: "8-K"
ticker: "SCNX"
cik: "0001382574"
company_name: "Scienture Holdings, Inc."
filed_at: "2025-05-22T23:59:59+00:00"
generated_at: "2026-05-20T17:51:06.386071+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Scienture Holdings CEO and President resign; Nasdaq bid-price deficiency received

## Summary
- CEO Suren Ajjarapu and Chairman resigned May 16; President Prashant Patel resigned May 20, both no disputes.
- Dr. Narasimhan Mani and Dr. Shankar Hariharan appointed co-CEOs effective May 20; Mani also President and director.
- Terminated purchase agreement with Arena Business Solutions Global SPC II effective May 22, no penalties.
- Nasdaq notice May 19: bid price below $1 for 30 days; 180 days until Nov 17, 2025 to regain compliance.

## SEC filing metadata
- accession: 0001641172-25-011945
- form_type: 8-K
- ticker: SCNX
- cik: 0001382574
- company_name: Scienture Holdings, Inc.
- filed_at: 2025-05-22T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.02, 1.01, 3.01, 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1382574/000164117225011945/0001641172-25-011945-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1382574/000164117225011945/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-011945
- JSON: https://secwatch.observer/filing/0001641172-25-011945.json
- Plain text: https://secwatch.observer/filing/0001641172-25-011945.txt

## Key facts
- Listing & Compliance Notices
  Scienture Holdings, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: minimum bid price
  - Rules: 5450(a)(1)
  source text: May 19, 2025, Scienture Holdings, Inc. (the “Company”) received a written notice from the Listing Qualifications department of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company was not in compliance with Nasdaq Listing Rule 5450(a)(1), as the minimum bid price of the Company’s common stock, par value $0.0001 (“Common Stock”) had been below $1.00 per share for 30 consecutive business days (the “Minimum Bid Price Requirement”). According to that notice, the Company has 180 calendar days, or until November 17, 2025, to regain compliance with the Minimum Bid Price Requirement. To
  evidence_url: https://www.sec.gov/Archives/edgar/data/1382574/000164117225011945/0001641172-25-011945-index.htm
- Executive change
  Suren Ajjarapu resigned as Chief Executive Officer and Chairman of the Board at Scienture Holdings, Inc..
  - Action: resigned
  - Role: Chief Executive Officer and Chairman of the Board
  source text: On May 16, 2025, as part of a planned leadership succession, Suren Ajjarapu advised the Company that he was resigning from his position as the Company’s Chief Executive Officer and Chairman of the Board effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1382574/000164117225011945/0001641172-25-011945-index.htm
- Executive change
  Dr. Narasimhan Mani was appointed as co-Chief Executive Officer, President and Director at Scienture Holdings, Inc..
  - Action: appointed
  - Role: co-Chief Executive Officer, President and Director
  source text: the Company’s board of directors appointed Dr. Narasimhan Mani, age 50, and Dr. Shankar Hariharan, age 68, to serve as co-Chief Executive Officers of the Company effective as of May 20, 2025.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1382574/000164117225011945/0001641172-25-011945-index.htm
- Executive change
  Prashant Patel resigned as President and Chief Operating Officer at Scienture Holdings, Inc..
  - Action: resigned
  - Role: President and Chief Operating Officer
  source text: As part of the planned leadership transition, Prashant Patel also advised the Company that he was resigning from his position as the Company’s President and Chief Operating Officer, effective as of May 20, 2025.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1382574/000164117225011945/0001641172-25-011945-index.htm
- Executive change
  Dr. Shankar Hariharan was appointed as Executive Chairman and co-Chief Executive Officer at Scienture Holdings, Inc..
  - Action: appointed
  - Role: Executive Chairman and co-Chief Executive Officer
  source text: The board of directors also appointed Dr. Mani to serve as a director on the Company’s board of directors to fill the vacancy created as a result of Mr. Ajjarapu’s resignation and appointed Dr. Hariharan to the position of Executive Chairman of the Company’s board of directors, each effective as of May 20, 2025.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1382574/000164117225011945/0001641172-25-011945-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.